Gauge-backed Rovia Clinical Research Acquires Delta Research Partners' Bastrop and West Monroe Sites

Rovia Clinical Research Acquires StudyMetrix Research and Coastal Research Institute

September 29, 2025

Healthcare Services

Rovia Clinical Research, backed by Gauge Capital with financing from Fidelity Direct Lending, acquired two clinical research sites — StudyMetrix Research (St. Charles, Missouri) and Coastal Research Institute (Fayetteville, North Carolina) — to expand its U.S. site network and capabilities in obesity, hepatology, gastroenterology, pain, and internal medicine. The deals were funded by a growth investment from Gauge Capital and debt and equity financing provided by Fidelity Direct Lending.

LongueVue Capital Invests in Summit Clinical Research

October 26, 2022

Healthcare Services

LongueVue Capital completed a growth investment in Summit Clinical Research, an integrated research organization (IRO) headquartered in San Antonio, Texas. The investment will provide financial and human capital to accelerate Summit's growth and expand its clinical trial site network and capabilities, particularly in hepatology and NASH research.

New Harbor Capital Invests in Monroe Biomedical Research

August 30, 2023

Healthcare Services

New Harbor Capital has completed a growth investment in Monroe Biomedical Research (MBR), a clinical trial site business headquartered in Monroe, North Carolina. New Harbor will partner with MBR's founder-led team to scale the company's multi-site clinical research capabilities and expand its patient recruitment and trial execution capacity.

GHO Capital Acquires Velocity Clinical Research

July 15, 2021

Healthcare Services

Global Healthcare Opportunities (GHO) has acquired Durham-based Velocity Clinical Research from NaviMed Capital and other investors. GHO intends to support Velocity’s roll-up strategy of clinical trial sites, expand its integrated site model (including investment in technology and decentralized trial capabilities) and pursue further geographic expansion, including into Europe.

Velocity Clinical Research Acquires Omega Medical Research and Buynak Clinical Research

June 16, 2020

Healthcare Services

Durham-based Velocity Clinical Research has acquired Omega Medical Research (Providence, Rhode Island) and Buynak Clinical Research (Valparaiso, Indiana), expanding its multi-site footprint to 12 sites across nine states. The deals, together with a strategic partnership with Elite Research Network, are intended to boost Velocity’s capacity for vaccine and COVID-19 treatment trials while adding geographic and therapeutic diversity.

Pinnacle Clinical Research (LongueVue Capital) Combines with South Texas Research Institute

January 10, 2023

Healthcare Services

Pinnacle Clinical Research, a LongueVue Capital portfolio company, has completed a combination with South Texas Research Institute (STRI). The deal expands Pinnacle's clinical site network to six dedicated locations, strengthens recruitment capabilities (notably for NASH/NAFLD trials) and increases geographic reach into the Rio Grande Valley.